Magnet Biomedicine
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- $50M
Investors
- 2
About Magnet Biomedicine
Based in Massachusetts, US, Magnet Biomedicine, Inc. operates as a research and development company for molecular glue medicines for the treatment of cancer, cardiovascular disease, and immune disorders. The company was co-founded by David Spiegel, Michael Rosbash, Richa Saxena, and Stuart Schreiber. In September 2023, Magnet Biomedicine, Inc. The company's platform discovers genuine molecular glues, offering exciting prospects for treating human diseases. Leveraging advancements in human biology and proteomics, the company’s platform identifies glues tailored for specific purposes for treatment purposes. These glues provide benefits such as improved targeting, synergistic effects on specific targets, and the ability to address historically challenging proteins. The company engages in combating various diseases and biological mechanisms, including cancer, cardiovascular issues, and immune disorders.
Who invested in Magnet Biomedicine
2 investors across 1 round
See all investors in Magnet Biomedicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 19, 2023
Amount
$50M
Investors
Questions about Magnet Biomedicine
Who invested in Magnet Biomedicine?
Magnet Biomedicine has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Magnet Biomedicine raised?
Magnet Biomedicine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Magnet Biomedicine last raise money?
Magnet Biomedicine's most recent round on record is a Series A, in Sep 2023.
What does Magnet Biomedicine do?
Based in Massachusetts, US, Magnet Biomedicine, Inc.
Where is Magnet Biomedicine headquartered?
Magnet Biomedicine is headquartered in Boston, US.
Which VCs invest in companies like Magnet Biomedicine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Magnet Biomedicine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Magnet Biomedicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.